Guillermo Adame
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guillermo Adame has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- A. Brian Mochon
Department of Pathology, College of Medicine–Phoenix, University of Arizona, Phoenix, AZ 85721, USA
2 shared publications - Constanza Giselle Taverna
Laboratorio Nacional de Referencia en Micología Clínica, Departamento Micología, Instituto Nacional de Enfermedades infecciosas (INEI), Administración Nacional de Laboratorios e Institutos de Salud (ANLIS, "Dr. Carlos G. Malbrán"), (C1282AFF), Ciudad Autónoma de Buenos Aires, Argentina
2 shared publications - David M. Engelthaler
Translational Genomics Research Institute
2 shared publications - Hayley D. Yaglom
Translational Genomics Research Institute
2 shared publications - Jane Emily Sykes
Department of Medicine & Epidemiology, School of Veterinary Medicine University of California Davis Davis California USA
2 shared publications - Jolene R. Bowers
Pathogen and Microbiome Division, Translational Genomics Research Institute, Flagstaff, AZ 86005, USA
2 shared publications
Latest Publications
- Open Access
- 20 August 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (8) , 1681
Phylogenomic Placement of American Southwest-Associated Clinical and Veterinary Isolates Expands Evidence for Distinct Cryptococcus gattii VGVI
Whole-genome sequencing has advanced our understanding of the population structure of the pathogenic species complex Cryptococcus gattii, which has allowed for the phylogenomic specification of previously described major molecular type groupings and novel lineages. Recently, isolates collected in Mexico in the 1960s were determined to be genetically distant from other known molecular types and were classified as VGVI. We sequenced four clinical isolates and one veterinary isolate collected in the southwestern United States and Argentina from 2012 to 2021. Phylogenomic analysis groups these genomes with those of the Mexican VGVI isolates, expanding VGVI into a clade and establishing this molecular type as a clinically important population. These findings also potentially expand the known Cryptococcus ecological range with a previously unrecognized endemic area.
- 20 August 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (8) , 1681
Open AccessPhylogenomic Placement of American Southwest-Associated Clinical and Veterinary Isolates Expands Evidence for Distinct Cryptococcus gattii VGVI
Whole-genome sequencing has advanced our understanding of the population structure of the pathogenic species complex Cryptococcus gattii, which has allowed for the phylogenomic specification of previously described major molecular type groupings and novel lineages. Recently, isolates collected in Mexico in the 1960s were determined to be genetically distant from other known molecular types and were classified as VGVI. We sequenced four clinical isolates and one veterinary isolate collected in the southwestern United States and Argentina from 2012 to 2021. Phylogenomic analysis groups these genomes with those of the Mexican VGVI isolates, expanding VGVI into a clade and establishing this molecular type as a clinically important population. These findings also potentially expand the known Cryptococcus ecological range with a previously unrecognized endemic area.
- Open Access
- 20 July 2022
- Published by MDPI AG in Preprints.org
Phylogenomic Placement of American Southwest-Associated Clinical and Veterinary Isolates Expands Evidence for Distinct Cryptococcus Gattii VGVI.
Whole-genome sequencing has advanced our understanding of the population structure of the pathogenic species complex Cryptococcus gattii, which has allowed for the phylogenomic specification of previously described major molecular type groupings and novel lineages. Recently, isolates collected in Mexico in the 1960s were determined to be genetically distant from other known molecular types and were classified as VGVI. We sequenced four clinical isolates and one veterinary isolate collected in the southwestern U.S. and Argentina during 2012-2021. Phylogenomic analysis groups these genomes with those of the Mexican VGVI isolates, expanding VGVI into a clade and establishing this molecular type as a clinically important population. These findings also potentially expand the known Cryptococcus ecological range with a previously unrecognized endemic area.
- 20 July 2022
- Published by MDPI AG in Preprints.org
Open AccessPhylogenomic Placement of American Southwest-Associated Clinical and Veterinary Isolates Expands Evidence for Distinct Cryptococcus Gattii VGVI.
Whole-genome sequencing has advanced our understanding of the population structure of the pathogenic species complex Cryptococcus gattii, which has allowed for the phylogenomic specification of previously described major molecular type groupings and novel lineages. Recently, isolates collected in Mexico in the 1960s were determined to be genetically distant from other known molecular types and were classified as VGVI. We sequenced four clinical isolates and one veterinary isolate collected in the southwestern U.S. and Argentina during 2012-2021. Phylogenomic analysis groups these genomes with those of the Mexican VGVI isolates, expanding VGVI into a clade and establishing this molecular type as a clinically important population. These findings also potentially expand the known Cryptococcus ecological range with a previously unrecognized endemic area.